{"schema_version":"secwatch.filing_event.v1","accession":"0001157523-21-001306","form_type":"8-K","ticker":"HLF","cik":"0001180262","company_name":"HERBALIFE LTD.","filed_at":"2021-11-02T23:59:59+00:00","discovered_at":"2026-05-14T18:04:11.804592+00:00","generated_at":"2026-06-28T14:55:24.313367+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Herbalife Q3 net sales down 6% to $1.4B; adjusted EPS and EBITDA beat high-end guidance","bullets":["Net sales of $1.4B, down 6% YoY; reported diluted EPS $1.09, adjusted diluted EPS $1.21, both up ~5% YoY.","Adjusted EBITDA of $222.4M; adjusted EPS and EBITDA exceeded high end of guidance ranges.","Reiterated FY2021 outlook: net sales growth 4.5%–8.5%, adjusted EPS $4.55–$4.95, adjusted EBITDA $860M–$910M.","Repurchased 3.5M shares for $162M in Q3; sales leaders active up 10% YoY ex-China.","Asia Pacific net sales +11% (India +46%, 5th straight record); N.America two-year stack +38% vs Q3 2019."],"urls":{"canonical":"https://secwatch.observer/filing/0001157523-21-001306","json":"https://secwatch.observer/filing/0001157523-21-001306.json","markdown":"https://secwatch.observer/filing/0001157523-21-001306.md","text":"https://secwatch.observer/filing/0001157523-21-001306.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1180262/000115752321001306/0001157523-21-001306-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1180262/000115752321001306/a52519635.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T14:55:24.313367+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}